DermTech (DMTK) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free DMTK Stock Alerts $0.50 -0.07 (-12.54%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | investorplace.comDMTK Stock Earnings: DermTech Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | msn.comDermTech GAAP EPS of -$0.58, revenue of $3.85MMay 14, 2024 | finance.yahoo.comDermTech Reports First-Quarter 2024 Financial ResultsApril 20, 2024 | investing.comDermTech stock downgraded by BTIG amid strategic reviewApril 19, 2024 | msn.comBTIG Downgrades DermTech (DMTK)April 19, 2024 | markets.businessinsider.comWhat Analysts Are Saying About DermTech StockApril 18, 2024 | marketwatch.comDermTech to Slash 56% of Workforce, Explore OptionsApril 18, 2024 | msn.comDermTech exploring strategic alternatives, cutting 56% of staffApril 18, 2024 | businesswire.comDermTech to Explore Strategic Alternatives and Implement Restructuring PlanApril 17, 2024 | finance.yahoo.comDermTech, Inc. (DMTK)March 8, 2024 | businesswire.comDermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative DermatologyMarch 7, 2024 | investing.comStephens cuts DermTech stock target to $1.50, keeps Equal Weight ratingMarch 2, 2024 | finance.yahoo.comDermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | benzinga.comRecap: DermTech Q4 EarningsFebruary 29, 2024 | businesswire.comDermTech Reports Fourth-Quarter 2023 Financial ResultsFebruary 28, 2024 | msn.comDermTech Q4 2023 Earnings PreviewFebruary 13, 2024 | finance.yahoo.comDermTech Announces Release Date for Fourth-quarter 2023 Financial ResultsFebruary 1, 2024 | markets.businessinsider.comDermTech International Registered ShsJanuary 31, 2024 | marketwatch.comDermTech to Cut Workforce by 15%, Six Months After Round of LayoffsJanuary 31, 2024 | finance.yahoo.comDermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline OperationsJanuary 18, 2024 | msn.comDermTech study finds melanoma test effective for all skin typesJanuary 18, 2024 | finance.yahoo.comDermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin TypesJanuary 16, 2024 | finance.yahoo.comDermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on AssayJanuary 8, 2024 | marketwatch.comDermTech Shares Rise 14% After Positive Results in Melanoma Test StudyJanuary 8, 2024 | seekingalpha.comDermTech stock rallies 18% on positive study for melanoma testJanuary 8, 2024 | finance.yahoo.comDermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)January 3, 2024 | benzinga.comDermTech Stock (NASDAQ:DMTK) Dividends: History, Yield and DatesDecember 29, 2023 | businesswire.comDERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmDecember 15, 2023 | businesswire.comDMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action ...December 14, 2023 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)December 13, 2023 | businesswire.comDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the ...December 13, 2023 | markets.businessinsider.comINVESTOR ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitDecember 12, 2023 | financialpost.comDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the FirmDecember 12, 2023 | businesswire.comDERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the FirmDecember 12, 2023 | markets.businessinsider.comDermTech Ongoing Deadline AlertDecember 11, 2023 | barrons.comIMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the FirmDecember 7, 2023 | barrons.comSHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of DermTech, Inc. (DMTK) of a Class Action Lawsuit and an Upcoming DeadlineDecember 6, 2023 | stockhouse.comDermTech Deadline AlertDecember 2, 2023 | barrons.comROSEN, A RANKED AND LEADING FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKNovember 29, 2023 | benzinga.comROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DMTKNovember 29, 2023 | barrons.comDMTK Investor Alert: Bronstein, Gewirtz & Grossman LLC Reminds DermTech, Inc. Investors with Substantial Losses to Contact the Firm!November 28, 2023 | benzinga.comLawsuit Deadline Alert: Investors who lost over $100,000 with shares of DermTech, Inc. (NASDAQ: DMTK) should contact the Shareholders FoundationNovember 26, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitNovember 22, 2023 | benzinga.comDMTK Investors Have Opportunity to Lead DermTech, Inc. Securities Fraud LawsuitNovember 22, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action LawsuitNovember 22, 2023 | barrons.comDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses of $100,000 to Contact the FirmNovember 21, 2023 | markets.businessinsider.comROSEN, NATIONAL TRIAL LAWYERS, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKNovember 20, 2023 | markets.businessinsider.comINVESTOR ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action LawsuitNovember 17, 2023 | benzinga.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMTKNovember 16, 2023 | morningstar.comDermTech Inc DMTK Get DermTech News Delivered to You Automatically Sign up to receive the latest news and ratings for DMTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. DMTK Media Mentions By Week DMTK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMTK News Sentiment▼-0.230.42▲Average Medical News Sentiment DMTK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMTK Articles This Week▼42▲DMTK Articles Average Week Get DermTech News Delivered to You Automatically Sign up to receive the latest news and ratings for DMTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Psychemedics News Exagen News Centogene News BioNexus Gene Lab News OpGen News Renalytix News Enzo Biochem News Personalis News ZIVO Bioscience News Cumberland Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DMTK) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy SykesDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DermTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
